Huntington disease-like syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:158266
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Huntington disease-like syndrome (HDL syndrome) is a group of rare neurodegenerative disorders that clinically resemble Huntington disease (HD) but are not caused by the characteristic CAG trinucleotide repeat expansion in the HTT gene. These conditions are sometimes collectively referred to as HD phenocopies or Huntington disease-like syndromes. Several distinct subtypes have been identified, including HDL1 (associated with PRNP gene mutations), HDL2 (caused by CTG/CAG repeat expansions in the JPH3 gene), HDL3 (mapped to chromosome 4p15.3 with autosomal recessive inheritance), and HDL4 (now recognized as spinocerebellar ataxia type 17, caused by TBP gene expansions). The grouping under Orphanet code 158266 encompasses these and potentially other phenocopies that share the core clinical presentation of HD without the classic genetic cause. The syndrome primarily affects the central nervous system, leading to progressive motor dysfunction including chorea (involuntary jerky movements), dystonia, rigidity, and bradykinesia. Psychiatric symptoms such as personality changes, depression, irritability, and psychosis are common and may precede motor symptoms. Cognitive decline progressing to dementia is a hallmark feature. Some subtypes may also present with cerebellar ataxia, seizures, or parkinsonism. Brain imaging typically reveals caudate nucleus atrophy and generalized cerebral atrophy similar to that seen in classic Huntington disease. There is currently no cure or disease-modifying treatment for Huntington disease-like syndromes. Management is symptomatic and supportive, paralleling the approach used in classic HD. Chorea may be treated with tetrabenazine or deutetrabenazine, psychiatric symptoms with appropriate psychotropic medications, and physical, occupational, and speech therapy can help maintain function. Genetic counseling is essential for affected families, as the inheritance pattern and recurrence risk vary depending on the specific subtype identified. Accurate molecular diagnosis is important to distinguish these conditions from classic HD and to guide appropriate genetic counseling.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Huntington disease-like syndrome.

View clinical trials →

No actively recruiting trials found for Huntington disease-like syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Huntington disease-like syndrome community →

No specialists are currently listed for Huntington disease-like syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Huntington disease-like syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Huntington disease-like syndromeForum →

No community posts yet. Be the first to share your experience with Huntington disease-like syndrome.

Start the conversation →

Latest news about Huntington disease-like syndrome

No recent news articles for Huntington disease-like syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Huntington disease-like syndrome

What is Huntington disease-like syndrome?

Huntington disease-like syndrome (HDL syndrome) is a group of rare neurodegenerative disorders that clinically resemble Huntington disease (HD) but are not caused by the characteristic CAG trinucleotide repeat expansion in the HTT gene. These conditions are sometimes collectively referred to as HD phenocopies or Huntington disease-like syndromes. Several distinct subtypes have been identified, including HDL1 (associated with PRNP gene mutations), HDL2 (caused by CTG/CAG repeat expansions in the JPH3 gene), HDL3 (mapped to chromosome 4p15.3 with autosomal recessive inheritance), and HDL4 (now r

At what age does Huntington disease-like syndrome typically begin?

Typical onset of Huntington disease-like syndrome is adult. Age of onset can vary across affected individuals.